Avoid antibiotics for low-grade fever: ICMR guidelines


PTI, Nov 27, 2022, 12:58 PM IST

New Delhi: The Indian Council of Medical Research has issued guidelines warning against the use of antibiotics for conditions such as low-grade fever and viral bronchitis while advising doctors to follow a timeline while prescribing them.

The ICMR guidelines stated that antibiotics should be prescribed for a duration of five days for skin and soft tissue infections, five days in case of community-acquired pneumonia, and eight days for hospital-acquired pneumonia.

“A clinical diagnosis most often helps us predict causative pathogens fitting into a clinical syndrome which would tailor the correct antibiotic rather than blindly relying on fever, procalcitonin levels, WBC counts, cultures or radiology to make a diagnosis of infection,” the guidelines said.

It stated limiting empiric antibiotic therapy to seriously ill patients.

Generally, empiric antibiotic therapy is only recommended for a select group of patients suffering from severe sepsis and septic shock, community-acquired pneumonia, ventilator-associated pneumonia, and necrotizing fasciitis.

Hence, it is important to start smart and then focus, i.e., evaluate if empiric therapy can be justified or de-escalated and then make a plan with regard to the duration of therapy, the guidelines said.

An ICMR survey conducted between January 1 and December 31, 2021, suggested that a big chunk of patients in India may no longer benefit from the use of carbapenem, a powerful antibiotic administered mainly in ICU settings for the treatment of pneumonia and septicemia, etc., as they have developed anti-microbial resistance to it.

The analysis of the data pointed towards a sustained increase in drug-resistant pathogens, resulting in difficulty to treat certain infections with the available medicines.

Resistance to Imipenem, which is used to treat infections caused by E coli bacteria, increased from 14 percent in 2016 to 36 percent in 2021.

The trend of decreasing susceptibility of bacteria to specific antibiotics was also observed with Klebsiella pneumoniae as it registered a drop from 65 percent in 2016 to 45 percent in 2020 and was at 43 percent in 2021.

The susceptibility term here was used to describe the vulnerability of the bacteria to the antibiotic. Carbapenem resistance isolates of E coli and K pneumoniae are also resistant to other antimicrobials, making it very challenging to treat carbapenem-resistant infections.

The resistance to broad-spectrum antibiotic carbapenem in respect to infections caused by Acinetobacter baumannii bacteria was recorded in 87.5 percent of the patients who were part of the study in 2021, limiting the availability of treatment options, the ICMR report said.

According to HAI Surveillance data included in this report, Acinetobacter causes almost 70 percent of urinary tract infections in critically sick (ICU) patients. High levels of carbapenem resistance in acinetobacter baumanii are therefore very alarming and limit treatment options in these patients.

Susceptibility of the same bacteria to minocycline is close to 50 percent, making it the most susceptible antibiotic after colistin for Acinetobacter baumannii, the report stated.

In Pseudomonas aeruginosa, another bacteria which causes infections in the blood, lungs (pneumonia) or other parts of the body after surgery, there is a consistent increase in susceptibility to all the major antipseudomonal drugs in the last few years.

According to the ICMR report, Staphylococcus aureus, which causes a wide variety of clinical diseases such as skin infections like abscesses and boils and sometimes pneumonia, endocarditis and osteomyelitis, susceptibility to erythromycin, clindamycin, ciprofloxacin, co-trimoxazole, and high-level mupirocin was more evident in MSSA (Methicillin-Sensitive Staphylococcus Aureus) when compared to multi-drug resistant strains such as MRSA (Methicillin-Resistant Staphylococcus aureus).

MRSA rates have increased every year from 2016 to 2021 (28.4 percent to 42.6 percent). Enterococci is another important pathogen that is quickly evolving and drug susceptibility has changed considerably in the last few years.

Several fungal pathogens like C. parapsilosis and C. glabrata are showing increasing resistance to commonly available antifungal medicines such as fluconazole, thus requiring close monitoring in the next few years.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Bengaluru techie allegedly rapes multiple women he befriended online; arrested

There are no big or small cases for court, every matter is important: CJI Chandrachud

US shoots down Chinese surveillance balloon, trying to recover its parts

SC gets 5 new judges, now two short of its full strength of 34

Imran Khan asks supporters to prepare for ‘Jail Bharo’ movement

Bengaluru: Congress complains to Police Commissioner about fake KPCC website “spreading lies”

Nation fast changing into developed one; Karnataka will drive this: Piyush Goyal


Related Articles More

After SC’s strong remarks over judges’ transfers, Rijiju says public is ‘malik’, nobody can give warning to anyone

India biggest exporter of vaccines, mobile phones: Union Minister Thakur

There are no big or small cases for court, every matter is important: CJI Chandrachud

SC gets 5 new judges, now two short of its full strength of 34

Number of airports in country to go up to over 200: Scindia

MUST WATCH

A successful coastal farmer growing watermelons

Mahesh Joshi Interview

Success Story of Mr bean

| Malpe fish market

Mahindra on Bengaluru waiter balancing 16 plates


Latest Additions

Asia Cup likely to be moved out of Pakistan, venue to be finalised in March

Guarantee cards on manifesto promises to reach every household: Ivan D’souza

After SC’s strong remarks over judges’ transfers, Rijiju says public is ‘malik’, nobody can give warning to anyone

Udupi resident loses Rs 1.06 lakhs in KYC updation scam

Bengaluru techie allegedly rapes multiple women he befriended online; arrested

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.